Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
IQVIA Holdings ( (IQV) ) has shared an update.
On September 2, 2025, IQVIA Holdings announced the appointment of Michael J. Fedock as Executive Vice President and Chief Financial Officer, effective February 28, 2026. This transition is part of the company’s CFO succession plan, with Fedock succeeding Ronald E. Bruehlman, who will retire and transition to a Senior Advisor role to the CEO. Fedock, with over 25 years of experience in the healthcare industry, has held several senior financial roles within IQVIA since joining in 2016. The transition aims to ensure continuity and support IQVIA’s long-term growth strategy, with Bruehlman having played a crucial role in the company’s transformation and growth since 2011.
The most recent analyst rating on (IQV) stock is a Buy with a $221.00 price target. To see the full list of analyst forecasts on IQVIA Holdings stock, see the IQV Stock Forecast page.
Spark’s Take on IQV Stock
According to Spark, TipRanks’ AI Analyst, IQV is a Outperform.
IQVIA’s strong financial performance and positive earnings call insights are the most significant contributors to its overall score. The company’s strategic focus on AI and robust revenue growth in key segments bolster its position. While the valuation is relatively high, it reflects confidence in future growth. Technical indicators support a bullish outlook, although the lack of a dividend yield is a minor drawback.
To see Spark’s full report on IQV stock, click here.
More about IQVIA Holdings
IQVIA Holdings Inc. is a leading global provider of clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries. The company’s solutions are powered by IQVIA Connected Intelligence, which delivers actionable insights and services based on high-quality health data, AI, advanced analytics, and extensive domain expertise. With approximately 90,000 employees in over 100 countries, IQVIA is committed to accelerating the development and commercialization of innovative medical treatments to improve patient outcomes and population health worldwide.
Average Trading Volume: 2,011,315
Technical Sentiment Signal: Buy
Current Market Cap: $32.44B
See more insights into IQV stock on TipRanks’ Stock Analysis page.